Comparing the Effectiveness of Artificial Intelligence Models in Predicting Ovarian Cancer Survival: A Systematic Review
- PMID: 40103563
- PMCID: PMC11920737
- DOI: 10.1002/cnr2.70138
Comparing the Effectiveness of Artificial Intelligence Models in Predicting Ovarian Cancer Survival: A Systematic Review
Abstract
Background: This systematic review investigates the use of machine learning (ML) algorithms in predicting survival outcomes for ovarian cancer (OC) patients. Key prognostic endpoints, including overall survival (OS), recurrence-free survival (RFS), progression-free survival (PFS), and treatment response prediction (TRP), are examined to evaluate the effectiveness of these algorithms and identify significant features that influence predictive accuracy.
Recent findings: A thorough search of four major databases-PubMed, Scopus, Web of Science, and Cochrane-resulted in 2400 articles published within the last decade, with 32 studies meeting the inclusion criteria. Notably, most publications emerged after 2021. Commonly used algorithms for survival prediction included random forest, support vector machines, logistic regression, XGBoost, and various deep learning models. Evaluation metrics such as area under the curve (AUC) (18 studies), concordance index (C-index) (11 studies), and accuracy (11 studies) were frequently employed. Age at diagnosis, tumor stage, CA-125 levels, and treatment-related factors were consistently highlighted as significant predictors, emphasizing their relevance in OC prognosis.
Conclusion: ML models demonstrate considerable potential for predicting OC survival outcomes; however, challenges persist regarding model accuracy and interpretability. Incorporating diverse data types-such as clinical, imaging, and molecular datasets-holds promise for enhancing predictive capabilities. Future advancements will depend on integrating heterogeneous data sources with multimodal ML approaches, which are crucial for improving prognostic precision in OC.
Keywords: artificial intelligence; cancer; machine learning; ovary; survival.
© 2025 The Author(s). Cancer Reports published by Wiley Periodicals LLC.
Conflict of interest statement
The authors declare no conflicts of interest.
Similar articles
-
The Use of Machine Learning for Analyzing Real-World Data in Disease Prediction and Management: Systematic Review.JMIR Med Inform. 2025 Jun 19;13:e68898. doi: 10.2196/68898. JMIR Med Inform. 2025. PMID: 40537090 Free PMC article.
-
Application of artificial intelligence in forecasting survival in high-grade glioma: systematic review and meta-analysis involving 79,638 participants.Neurosurg Rev. 2025 Feb 15;48(1):240. doi: 10.1007/s10143-025-03419-y. Neurosurg Rev. 2025. PMID: 39954167
-
Use of machine learning to predict bladder cancer survival outcomes: a systematic literature review.Expert Rev Pharmacoecon Outcomes Res. 2023 Jul-Dec;23(7):761-771. doi: 10.1080/14737167.2023.2224963. Epub 2023 Jun 19. Expert Rev Pharmacoecon Outcomes Res. 2023. PMID: 37306511
-
Are Current Survival Prediction Tools Useful When Treating Subsequent Skeletal-related Events From Bone Metastases?Clin Orthop Relat Res. 2024 Sep 1;482(9):1710-1721. doi: 10.1097/CORR.0000000000003030. Epub 2024 Mar 22. Clin Orthop Relat Res. 2024. PMID: 38517402
-
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.Health Technol Assess. 2001;5(28):1-110. doi: 10.3310/hta5280. Health Technol Assess. 2001. PMID: 11701100
References
-
- Bray F., Laversanne M., Sung H., et al., “Global Cancer Statistics 2022: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries,” CA: A Cancer Journal for Clinicians 74, no. 3 (2024): 229–263. - PubMed
-
- Shaik B., Zafar T., Balasubramanian K., and Gupta S. P., “An Overview of Ovarian Cancer: Molecular Processes Involved and Development of Target‐Based Chemotherapeutics,” Current Topics in Medicinal Chemistry 21, no. 4 (2021): 329–346. - PubMed
-
- Jayson G. C., Kohn E. C., Kitchener H. C., and Ledermann J. A., “Ovarian Cancer,” Lancet 384, no. 9951 (2014): 1376–1388. - PubMed
-
- Lheureux S., Gourley C., Vergote I., and Oza A. M., “Epithelial Ovarian Cancer,” Lancet 393, no. 10177 (2019): 1240–1253. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous